Drug intelligence / Profile preview

DFD-05

Development stage: Phase 2
Lead developer: Dr. Reddy's Laboratories
Modality: Small Molecules
Administration: Topical

Overview

**DFD-05** is a proprietary topical cream developed by Dr. Reddy's Laboratories for treatment of common warts. It was evaluated against an active-control cream in the completed Phase 2 study NCT02798419. Publicly available trial records identify the product as DFD05 Cream, but do not disclose its active pharmaceutical ingredient, molecular structure, concentration, or specific mechanism of action. ([inclinicaltrials.com](https://inclinicaltrials.com/common-warts/NCT02798419/))

Other names: 5-fluorouracil cream5-FU cream

Targets

TS (Thymidylate synthase)

Beyond the preview

Go deeper on DFD-05.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DFD-05.

Explore the full profile